Stanley Druckenmiller出售了他的大部分Teva和TSM股份,购买了301M的金融ETF,表明向金融部门的赌注转变。 Stanley Druckenmiller sold most of his Teva and TSM shares, bought $301M in financial ETF, signaling shift to financial sector bets.

2025年,亿万富翁投资者斯坦利·德鲁肯米勒(Stanley Druckenmiller)将Teva制药公司的股份减少了65%,将台湾半导体的股份减少了29%,这可能是由于2024年后期以来的强劲收益所致。 In Q4 2025, billionaire investor Stanley Druckenmiller reduced his stakes in Teva Pharmaceutical by 65% and Taiwan Semiconductor by 29%, likely due to strong gains since late 2024. 同时,他向国家街道金融选择部门SPDR ETF投资3.01亿美元,成为他的基金第二大持有者。 He simultaneously invested $301 million in the State Street Financial Select Sector SPDR ETF, making it his fund’s second-largest holding. 这一转变表明金融部门的战略性风险,尽管美联储自2024年9月以来一直在放宽利率,但可能会在未来的利率稳定或上方面进行投注. The shift suggests a strategic move toward financial sector exposure, potentially betting on future interest rate stability or increases despite the Fed’s ongoing rate-easing cycle since September 2024.